Development of Thrombospondin 1 shRNA as anti-cancer agent
博士 === 國立成功大學 === 基礎醫學研究所 === 102 === Induction of thrombospondin 1 (TSP-1) is generally assumed to suppress tumors by inhibiting angiogenesis; however, it is less clear how the TSP-1 in dendritic cells (DCs) influences tumor progression. We hypothesized that silencing TSP-1 expression in DCs via sk...
Main Authors: | Tzu-YangWeng, 翁子洋 |
---|---|
Other Authors: | Ming-Derg Lai |
Format: | Others |
Language: | zh-TW |
Published: |
2014
|
Online Access: | http://ndltd.ncl.edu.tw/handle/36626879905977351109 |
Similar Items
-
Suppression of cancer progression by MGAT1 shRNA knockdown.
by: Reza Beheshti Zavareh, et al.
Published: (2012-01-01) -
Optimized PCR conditions and increased shRNA fold representation improve reproducibility of pooled shRNA screens.
by: Žaklina Strezoska, et al.
Published: (2012-01-01) -
Monitoring on truncation of AMCase treated with shRNA
by: WANG,YUNG-HSIANG, et al.
Published: (2016) -
Improved siRNA/shRNA functionality by mismatched duplex.
by: Haoquan Wu, et al.
Published: (2011-01-01) -
Synthetic lethal and shRNA screen in oral cancer cell lines
by: Meng-Yi Lin, et al.
Published: (2008)